• Through its legal department, the Politécnico combats illicit activities on digital platforms where counterfeit products are sold, posing potential health risks.
• To date, more than 660 infringing profiles have been removed from social media; 1,383 counterfeit product listings have been taken down from websites.
• The public is urged not to be deceived by fraudulent products; the Politécnico disclaims any responsibility or health damage resulting from their use.
The Instituto Politécnico Nacional (IPN) reports that it has detected websites impersonating its identity to promote allegedly official products from the Institute, specifically its registered brand Transferon®.
The product is manufactured through a unique, standardized, and controlled process that guarantees quality. For this reason, the public is urged to safeguard their well-being and purchase it exclusively from the Polytechnic, following a prior medical consultation, to avoid health risks.
Due to the increasing illegal sale of this drug, IPN continuously works to disable fraudulent websites that exhibit these characteristics as a permanent measure against counterfeiting and to protect its brand.
Transferon® is not sold on any digital platform, nor through distributors who illegally claim to be “authorized.”
The IPN is committed to combating any e-commerce platform, social media account, or website attempting to market counterfeit versions of its products. To achieve this, legal action is taken against individuals and entities responsible for these sites, aiming to shut down illegal production centers.
Regarding this problem, the IPN has carried out the following actions
• More than 660 infringing profiles were removed from social media platforms.
• 1,383 counterfeit product listings were taken down from e-commerce sites.
• 1,480 reports of illegal products were submitted on the Mercado Libre platform.
Additionally, 183 publications on websites, social media, and television were identified, of which 127 were removed due to legal and administrative actions taken.
The only way to acquire Transferon® is through the Unidad de Servicios Externos e Investigación Clínica (USEIC) of the Escuela Nacional de Ciencias Biológicas (ENCB) or at the Centro de Estudios Científicos y Tecnológicos (CECyT) No. 6 “Miguel Othón de Mendizábal.”
Information and free appointments with specialists qualified to prescribe Transferon® can be requested at the IPN's official web pages: https://www.encb.ipn.mx/ (the official site of the Escuela Nacional de Ciencias Biológicas), http://useic.com.mx/ (the official site of the USEIC), https://www.transformatusalud.com.mx/ (the official site of the research on Dialyzable Leukocyte Extracts), and the CECyT No. 6.
El Transferon® is a dialyzable leukocyte extract composed of more than 400 peptide molecules, fully characterized and sequenced by IPN. The high-quality standards that back it have led to patent protection until 2032 at both national and international levels. This recognition positions IPN as the only educational institution with a health license to manufacture this blood-derived product, having developed it entirely in-house.
We reiterate the call to the public not to be deceived by fraudulent products misusing the IPN’s name and prestige for commercial speculation. Verifying the authenticity of the product before purchase is strongly recommended, as this institution disclaims any responsibility for consequences arising from its use or consumption.
INSTITUTO POLITÉCNICO NACIONAL
D.R. Instituto Politécnico Nacional (IPN). Av. Luis Enrique Erro S/N, Unidad Profesional Adolfo López Mateos, Zacatenco, Alcaldía Gustavo A. Madero, C.P. 07738, Ciudad de México. Conmutador: 55 57 29 60 00 / 55 57 29 63 00.
Esta página es una obra intelectual protegida por la Ley Federal del Derecho de Autor, puede ser reproducida con fines no lucrativos, siempre y cuando no se mutile, se cite la fuente completa y su dirección electrónica; su uso para otros fines, requiere autorización previa y por escrito de la Dirección General del Instituto.
